A review of dietary influences on cardiovascular health: Part 1: The role of dietary nutrients

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 13, Issue 3, 2013, Pages 208-230

  Stradling, Clare ^a   Hamid, Mash ^b   Fisher, Katherine ^a   Taheri, Shahrad ^b   Thomas, G Neil ^b,c  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular disease; Dietary fats; Dietary fiber; Fish oils; Fruit; Glycemic index; Nuts; Vegetables

Indexed keywords

CARBOHYDRATE; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; VITAMIN;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; FISH; FRUIT; GLYCEMIC INDEX; HUMAN; LIFESTYLE MODIFICATION; NUT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SODIUM INTAKE; SYSTEMATIC REVIEW (TOPIC); VEGETABLE;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; DIET; FOOD; HUMANS; RISK FACTORS;

EID: 84893448866     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X13666131129102632     Document Type: Review

References (167)

1. WHO, Cardiovascular Diseases (CVDs). World Health Organisation Media Centre: Geneva, 2011.
2. Jacques, P. F.; Tucker, K. L. Are dietary patterns useful for understanding the role of diet in chronic disease? Am. J. Clin. Nutr., 2001, 73 (1), 1-2.
3. McKeown, P. P.; Logan, K.; McKinley, M. C.; Young, I. S.; Woodside, J. V. Session 4: CVD, diabetes and cancer: Evidence for the use of the Mediterranean diet in patients with CHD. Proc. Nutr. Soc., 2010, 69(1), 45-60.
4. Thomas, G. N.; Cheung, B. M.; Ho, S. Y.; Macfarlane, D. J.; Deng, H. B.; McGhee, S. M.; Woo, J.; Lam, T. H.; Tomlinson, B. Overview of dietary influences on atherosclerotic vascular disease: epidemiology and prevention. Cardiovasc. Hematol. Disord. Drug Targets., 2007, 7(2), 87-97.
5. Keys, A. Coronary heart disease in seven countries. Circulation, 1970, 41, I1-I211.
6. Skeaff, C. M.; Miller, J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann. Nutr. Metab., 2009, 5(1-3), 173-201.
7. Siri-Tarino, P. W.; Sun, Q.; Hu, F. B.; Krauss, R. M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr., 2010, 91(3), 535-46.
8. Stamler, J. Diet-heart: a problematic revisit. Am. J. Clin. Nutr., 2010, 91(3), 497-9.
9. Hooper, L.; Summerbell Carolyn, D.; Thompson, R.; Sills, D.; Roberts Felicia, G.; Moore, H.; Davey Smith, G. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev., 2011, (7), CD002137.
10. Jakobsen, M. U.; O'Reilly, E. J.; Heitmann, B. L.; Pereira, M. A.; Balter, K.; Fraser, G. E.; Goldbourt, U.; Hallmans, G.; Knekt, P.; Liu, S.; Pietinen, P.; Spiegelman, D.; Stevens, J.; Virtamo, J.; Willett, W. C.; Ascherio, A. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr., 2009, 89(5), 1425-32.
11. Jakobsen, M. U.; Dethlefsen, C.; Joensen, A. M.; Stegger, J.; Tjonneland, A.; Schmidt, E. B.; Overvad, K. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am. J. Clin. Nutr., 2010, 91(6), 1764-8.
12. Mozaffarian, D.; Micha, R.; Wallace, S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med., 2010, 7(3), e1000252.
13. Ramsden, C. E.; Hibbeln, J. R.; Majchrzak, S. F.; Davis, J. M. n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br. J. Nutr., 2010, 104(11), 1586-1600.
14. Mozaffarian, D.; Clarke, R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur. J. Clin. Nutr., 2009, 63(2), S22-s33.
15. Hooper, L.; Kroon, P. A.; Rimm, E. B.; Cohn, J. S.; Harvey, I.; Le Cornu, K. A.; Ryder, J. J.; Hall, W. L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2008, 88(1), 38-50.
16. Key, T. J.; Fraser, G. E.; Thorogood, M.; Appleby, P. N.; Beral, V.; Reeves, G.; Burr, M. L.; Chang-Claude, J.; Frentzel-Beyme, R.; Kuzma, J. W.; Mann, J.; McPherson, K. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76, 000 men and women in five prospective studies. Public Health Nutr., 1998, 1(1), 33-41.
17. Hu, F. B.; Bronner, L.; Willett, W. C.; Stampfer, M. J.; Rexrode, K. M.; Albert, C. M.; Hunter, D.; Manson, J. E. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J. Am. Med. Assoc., 2002, 287(14), 1815-21.
18. He, K.; Song, Y.; Daviglus, M. L.; Liu, K.; Van Horn, L.; Dyer, A. R.; Goldbourt, U.; Greenland, P. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke, 2004, 35, 1538-42.
19. Marckmann, P.; Gronbaek, M. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur. J. Clin. Nutr., 1999, 53(8), 585-90.
20. Marchioli, R.; Barzi, F.; Bomba, E.; Chieffo, C.; Di Gregorio, D.; Di Mascio, R.; Franzosi, M. G.; Geraci, E.; Levantesi, G.; Maggioni, A. P.; Mantini, L.; Marfisi, R. M.; Mastrogiuseppe, G.; Mininni, N.; Nicolosi, G. L.; Santini, M.; Schweiger, C.; Tavazzi, L.; Tognoni, G.; Tucci, C.; Valagussa, F. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation, 2002, 105, 1897-903.
21. GISSI-Prevenzione Investigators, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet, 1999, 354(9177), 447-55.
22. Burr, M. L.; Fehily, A. M.; Gilbert, J. F.; Rogers, S.; Holliday, R. M.; Sweetnam, P. M.; Elwood, P. C.; Deadman, N. M. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet, 1989, 2(8666), 757-61.
23. Ness, A. R.; Hughes, J.; Elwood, P. C.; Whitley, E.; Smith, G. D.; Burr, M. L. The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART). Eur. J. Clin. Nutr., 2002, 56(6), 512-8.
24. Bucher, H. C.; Hengstler, P.; Schindler, C.; Meier, G. N-3 polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. Am. J. Med., 2002, 112, 298-304.
25. Hooper, L.; Harrison Roger, A.; Summerbell Carolyn, D.; Moore, H.; Worthington Helen, V.; Ness, A.; Capps, N.; Davey Smith, G.; Riemersma, R.; Ebrahim, S. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst. Rev., 2004, (4), CD003177.
26. Pan, A.; Yu, D.; Demark-Wahnefried, W.; Franco, O. H.; Lin, X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am. J. Clin. Nutr. 2009, 90(2), 288-297.
27. Marik, P. E.; Varon, J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin. Cardiol., 2009, 32(7), 365-372.
28. Leon, H.; Shibata, M. C.; Sivakumaran, S.; Dorgan, M.; Chatterley, T.; Tsuyuki, R. T. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ, 2008, 337, a2931.
29. Zhao, Y. T.; Chen, Q.; Sun, Y. X.; Li, X. B.; Zhang, P.; Xu, Y.; Guo, J. H. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann. Med., 2009, 41(4), 301-10.
30. Yokoyama, M.; Origasa, H.; Matsuzaki, M.; Matsuzawa, Y.; Saito, Y.; Ishikawa, Y.; Oikawa, S.; Sasaki, J.; Hishida, H.; Itakura, H.; Kita, T.; Kitabatake, A.; Nakaya, N.; Sakata, T.; Shimada, K.; Shirato, K. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. The Lancet, 2007, 369(9567), 1090-1098.
31. Tavazzi, L.; Maggioni, A. P.; Marchioli, R.; Barlera, S.; Franzosi, M. G.; Latini, R.; Lucci, D.; Nicolosi, G. L.; Porcu, M.; Tognoni, G. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet, 2008, 372(9645), 1223-30.
32. Rauch, B.; Schiele, R.; Schneider, S.; Diller, F.; Victor, N.; Gohlke, H.; Gottwik, M.; Steinbeck, G.; Del Castillo, U.; Sack, R.; Worth, H.; Katus, H.; Spitzer, W.; Sabin, G.; Senges, J. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation, 2010, 122 (21), 2152-9.
33. Kromhout, D.; Giltay, E. J.; Geleijnse, J. M. n-3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med., 2010, 363(21), 2015-26.
34. Filion, K. B.; El Khoury, F.; Bielinski, M.; Schiller, I.; Dendukuri, N.; Brophy, J. M. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord., 2010, 10, 24.
35. Chen, Q.; Cheng, L. Q.; Xiao, T. H.; Zhang, Y. X.; Zhu, M.; Zhang, R.; Li, K.; Wang, Y.; Li, Y. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Cardiovasc. Drugs Ther., 2011, 25(3), 259-65.
36. Eslick, G. D.; Howe, P. R.; Smith, C.; Priest, R.; Bensoussan, A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int. J. Cardiol., 2009, 136 (1), 4-16.
37. Pase, M. P.; Grima, N. A.; Sarris, J. The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am. J. Clin. Nutr., 2011, 93(2), 446-54.
38. Eckel, R. H. The fish oil story remains fishy. Circulation 2010, 122 (21), 2110-2112.
39. Stradling, C.; Chen, Y. F.; Russell, T.; Connock, M.; Thomas, G. N.; Taheri, S. The Effects of Dietary Intervention on HIV Dyslipidaemia: A Systematic Review and Meta-Analysis. PLoS ONE, 2012, 7(6), e38121.
40. AHA Scientific Statement: Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease, #71-0241. Circ. Res., 2002, 106, 2747-2757.
41. Kelly, J. H., Jr.; Sabate, J. Nuts and coronary heart disease: an epidemiological perspective. Br. J. Nutr., 2006, 96(2), S61-7.
42. Hu, F. B.; Stampfer, M. J.; Manson, J. E.; Rimm, E. B.; Colditz, G. A.; Rosner, B. A.; Speizer, F. E.; Hennekens, C. H.; Willett, W. C. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ, 1998, 317(7169), 1341-5.
43. Fraser, G. E.; Sabate, J.; Beeson, W. L.; Strahan, T. M. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch. Intern. Med., 1992, 152 (7), 1416-24.
44. Albert, C. M.; Gaziano, J. M.; Willett, W. C.; Manson, J. E. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch. Intern. Med., 2002, 162(12), 1382-7.
45. Kushi, L. H.; Folsom, A. R.; Prineas, R. J.; Mink, P. J.; Wu, Y.; Bostick, R. M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med., 1996, 334(18), 1156-62.
46. Banel, D. K.; Hu, F. B. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am. J. Clin. Nutr., 2009, 90(1), 56-63.
47. Ros, E.; Nunez, I.; Perez-Heras, A.; Serra, M.; Gilabert, R.; Casals, E.; Deulofeu, R. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation, 2004, 109(13), 1609-14.
48. Phung, O. J.; Makanji, S. S.; White, C. M.; Coleman, C. I. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J. Am. Diet. Assoc., 2009, 109(5), 865-73.
49. Li, S. C.; Liu, Y. H.; Liu, J. F.; Chang, W. H.; Chen, C. M.; Chen, C. Y. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism, 2011, 60(4), 474-9.
50. Wien, M.; Bleich, D.; Raghuwanshi, M.; Gould-Forgerite, S.; Gomes, J.; Monahan-Couch, L.; Oda, K. Almond consumption and cardiovascular risk factors in adults with prediabetes. J. Am. Coll. Nutr., 2010, 29(3): 189-97.
51. Sabate, J.; Oda, K.; Ros, E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch. Intern. Med., 2010, 170(9), 821-7.
52. Jenkins, D. J.; Kendall, C. W.; Marchie, A.; Parker, T. L.; Connelly, P. W.; Qian, W.; Haight, J. S.; Faulkner, D.; Vidgen, E.; Lapsley, K. G.; Spiller, G. A. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation, 2002, 106 (11), 1327-32.
53. Bazzano, L. A.; He, J.; Ogden, L. G.; Loria, C. M.; Vupputuri, S.; Myers, L.; Whelton, P. K. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am. J. Clin. Nutr., 2002, 76(1), 93-9.
54. Joshipura, K. J.; Hu, F. B.; Manson, J. E.; Stampfer, M. J.; Rimm, E. B.; Speizer, F. E.; Colditz, G.; Ascherio, A.; Rosner, B.; Spiegelman, D.; Willett, W. C. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med., 2001, 134(12), 1106-14.
55. Liu, S.; Manson, J. E.; Lee, I. M.; Cole, S. R.; Hennekens, C. H.; Willett, W. C.; Buring, J. E. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am. J. Clin. Nutr., 2000, 72(4), 922-8.
56. He, F. J.; Nowson, C. A.; Lucas, M.; MacGregor, G. A. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J. Hum. Hypertens., 2007, 21(9), 717-28.
57. Hung, H. C.; Joshipura, K. J.; Jiang, R.; Hu, F. B.; Hunter, D.; Smith-Warner, S. A.; Colditz, G. A.; Rosner, B.; Spiegelman, D.; Willett, W. C. Fruit and vegetable intake and risk of major chronic disease. J. Natl. Cancer Inst., 2004, 96(21), 1577-84.
58. Oude Griep, L. M.; Geleijnse, J. M.; Kromhout, D.; Ocke, M. C.; Verschuren, W. M. Raw and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a population-based cohort study in the Netherlands. PLoS ONE, 2010, 5(10), e13609.
59. Padayatty, S. J.; Levine, M. Fruit and vegetables: think variety, go ahead, eat! Am. J. Clin. Nutr., 2008, 87(1), 5-7.
60. Hansen, L.; Dragsted, L. O.; Olsen, A.; Christensen, J.; Tjonneland, A.; Schmidt, E. B.; Overvad, K. Fruit and vegetable intake and risk of acute coronary syndrome. Br. J. Nutr., 2010, 104(2), 248-55.
61. Dauchet, L.; Ferrieres, J.; Arveiler, D.; Yarnell, J. W.; Gey, F.; Ducimetiere, P.; Ruidavets, J. B.; Haas, B.; Evans, A.; Bingham, A.; Amouyel, P.; Dallongeville, J. Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study. Br. J. Nutr., 2004, 92(6), 963-72.
62. Mizrahi, A.; Knekt, P.; Montonen, J.; Laaksonen, M. A.; Heliovaara, M.; Jarvinen, R. Plant foods and the risk of cerebrovascular diseases: a potential protection of fruit consumption. Br. J. Nutr., 2009, 102(7), 1075-83.
63. Huxley, R. R.; Neil, H. A. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr., 2003, 57(8), 904-8.
64. Johnsen, S. P.; Overvad, K.; Stripp, C.; Tjonneland, A.; Husted, S. E.; Sorensen, H. T. Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women. Am. J. Clin. Nutr., 2003, 78(1), 57-64.
65. Joshipura, K. J.; Ascherio, A.; Manson, J. E.; Stampfer, M. J.; Rimm, E. B.; Speizer, F. E.; Hennekens, C. H.; Spiegelman, D.; Willett, W. C. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA, 1999, 282(13), 1233-9.
66. Joshipura, K. J.; Hung, H. C.; Li, T. Y.; Hu, F. B.; Rimm, E. B.; Stampfer, M. J.; Colditz, G.; Willett, W. C. Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr., 2009, 12(1), 115-21.
67. Takachi, R.; Inoue, M.; Ishihara, J.; Kurahashi, N.; Iwasaki, M.; Sasazuki, S.; Iso, H.; Tsubono, Y.; Tsugane, S. Fruit and vegetable intake and risk of total cancer and cardiovascular disease: Japan Public Health Center-Based Prospective Study. Am. J. Epidemiol., 2008, 167(1), 59-70.
68. Kokubo, Y.; Iso, H.; Ishihara, J.; Okada, K.; Inoue, M.; Tsugane, S. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation, 2007, 116(22), 2553-62.
69. Harland, J. I.; Haffner, T. A. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis, 2008, (1), 13-27.
70. Anderson, J. W.; Bush, H. M. Soy Protein Effects on Serum Lipoproteins: A Quality Assessment and Meta-Analysis of Randomized, Controlled Studies. J. Am. Coll. Nutr., 2011, 30(2), 79-91.
71. Jenkins, D. J. A.; Mirrahimi, A.; Srichaikul, K.; Berryman, C. E.; Wang, L.; Carleton, A.; Abdulnour, S.; Sievenpiper, J. L.; Kendall, C. W. C.; Kris-Etherton, P. M. Soy Protein Reduces Serum Cholesterol by Both Intrinsic and Food Displacement Mechanisms. J. Nutr., 2010, 140(12), 2302S-2311S.
72. Taku, K.; Lin, N.; Cai, D.; Hu, J.; Zhao, X.; Zhang, Y.; Wang, P.; Melby, M. K.; Hooper, L.; Kurzer, M. S.; Mizuno, S.; Ishimi, Y.; Watanabe, S. Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and metaanalysis of randomized placebo-controlled trials. J. Hypertens., 2010, 28(10), 1971-82.
73. Li, S. H.; Liu, X. X.; Bai, Y. Y.; Wang, X. J.; Sun, K.; Chen, J. Z.; Hui, R. T. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am. J. Clin. Nutr., 2010, 91(2), 480-486.
74. Dong, J. Y.; Tong, X.; Wu, Z. W.; Xun, P. C.; He, K.; Qin, L. Q. Effect of soya protein on blood pressure: a meta-analysis of randomised controlled trials. Br. J. Nutr., 2011, 106(3), 317-326.
75. Barclay, A. W.; Petocz, P.; McMillan-Price, J.; Flood, V. M.; Prvan, T.; Mitchell, P.; Brand-Miller, J. C. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am. J. Clin. Nutr., 2008, 87(3), 627-37.
76. Jenkins, D. J.; Wolever, T. M.; Taylor, R. H.; Barker, H.; Fielden, H.; Baldwin, J. M. Bowling, A. C.; Newman, H. C.; Jenkins, A. L.; Goff, D. V., Glycemic index of foods: a physiological basis for carbohydrate exchange. Am. J. Clin. Nutr., 1981, 34(3), 362-6.
77. Neuhouser, M. L.; Tinker, L. F.; Thomson, C.; Caan, B.; Horn, L. V.; Snetselaar, L.; Parker, L. M.; Patterson, R. E.; Robinson-O'Brien, R.; Beresford, S. A.; Shikany, J. M. Development of a glycemic index database for food frequency questionnaires used in epidemiologic studies. J. Nutr., 2006, 136(6), 1604-9.
78. Beulens, J. W.; de Bruijne, L. M.; Stolk, R. P.; Peeters, P. H.; Bots, M. L.; Grobbee, D. E.; van der Schouw, Y. T. High dietary glycemic load and glycemic index increase risk of cardiovascular disease among middle-aged women: a population-based follow-up study. J. Am. Coll. Cardiol., 2007, 50(1), 14-21.
79. Grau, K.; Tetens, I.; Bjornsbo, K. S.; Heitman, B. L. Overall glycaemic index and glycaemic load of habitual diet and risk of heart disease. Public Health Nutr., 2011, 14(1), 109-18.
80. Levitan, E. B.; Mittleman, M. A.; Hakansson, N.; Wolk, A. Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middle-aged and older Swedish men. Am. J. Clin. Nutr., 2007, 85(6), 1521-6.
81. Liu, S.; Willett, W. C.; Stampfer, M. J.; Hu, F. B.; Franz, M.; Sampson, L.; Hennekens, C. H.; Manson, J. E. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am. J. Clin. Nutr., 2000, 71(6), 1455-61.
82. Levitan, E. B.; Mittleman, M. A.; Wolk, A. Dietary glycaemic index, dietary glycaemic load and incidence of myocardial infarction in women. Br. J. Nutr., 2010, 103(7), 1049-55.
83. Mursu, J.; Virtanen, J. K.; Rissanen, T. H.; Tuomainen, T. P.; Nykanen, I.; Laukkanen, J. A.; Kortelainen, R.; Voutilainen, S. Glycemic index, glycemic load, and the risk of acute myocardial infarction in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Nutr. Metab. Cardiovasc. Dis., 2011, 21(2), 144-9.
84. Oh, K.; Hu, F. B.; Cho, E.; Rexrode, K. M.; Stampfer, M. J.; Manson, J. E.; Liu, S.; Willett, W. C., Carbohydrate intake, glycemic index, glycemic load, and dietary fiber in relation to risk of stroke in women. Am. J. Epidemiol. 2005, 161 (2), 161-9.
85. Sieri, S.; Krogh, V.; Berrino, F.; Evangelista, A.; Agnoli, C.; Brighenti, F.; Pellegrini, N.; Palli, D.; Masala, G.; Sacerdote, C.; Veglia, F.; Tumino, R.; Frasca, G.; Grioni, S.; Pala, V.; Mattiello, A.; Chiodini, P.; Panico, S. Dietary glycemic load and index and risk of coronary heart disease in a large italian cohort: the EPICOR study. Arch. Intern. Med., 2010, 170(7), 640-7.
86. van Dam, R. M.; Visscher, A. W.; Feskens, E. J.; Verhoef, P.; Kromhout, D. Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study. Eur. J. Clin. Nutr., 2000, 54(9), 726-31.
87. Dong, J. Y.; Zhang, Y. H.; Wang, P.; Qin, L. Q. Meta-analysis of dietary glycemic load and glycemic index in relation to risk of coronary heart disease. Am. J. Cardiol., 2012, 109(11), 1608-13.
88. Knopp, R. H.; Paramsothy, P.; Retzlaff, B. M.; Fish, B.; Walden, C.; Dowdy, A.; Tsunehara, C.; Aikawa, K.; Cheung, M. C. Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr. Atheroscler. Rep., 2005, 7(6), 472-9.
89. Dong, J. Y.; Zhang, L.; Zhang, Y. H.; Qin, L. Q. Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Br. J. Nutr., 2011, 106(11), 1649-54.
90. Seal, C. J. Whole grains and CVD risk. Proc. Nutr. Soc., 2006, 65(1), 24-34.
91. Harris, K. A.; Kris-Etherton, P. M. Effects of whole grains on coronary heart disease risk. Curr. Atheroscler. Rep., 2010, 12(6), 368-76.
92. Jonnalagadda, S. S.; Harnack, L.; Liu, R. H.; McKeown, N.; Seal, C.; Liu, S.; Fahey, G. C. Putting the whole grain puzzle together: health benefits associated with whole grains-summary of American Society for Nutrition 2010 Satellite Symposium. J. Nutr., 2011, 141(5), 1011S-22S.
93. Flight, I.; Clifton, P. Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literature. Eur. J. Clin. Nutr., 2006, 60(10), 1145-59.
94. Wang, L.; Gaziano, J. M.; Liu, S.; Manson, J. E.; Buring, J. E.; Sesso, H. D. Whole-and refined-grain intakes and the risk of hypertension in women. Am. J. Clin. Nutr., 2007, 86(2), 472-9.
95. Liu, S.; Willett, W. C.; Manson, J. E.; Hu, F. B.; Rosner, B.; Colditz, G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am. J. Clin. Nutr., 2003, 78(5), 920-7.
96. Jacobs, D. R., Jr.; Meyer, K. A.; Kushi, L. H.; Folsom, A. R. Wholegrain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am. J. Clin. Nutr., 1998, 68(2), 248-57.
97. Liu, S.; Stampfer, M. J.; Hu, F. B.; Giovannucci, E.; Rimm, E.; Manson, J. E.; Hennekens, C. H.; Willett, W. C. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am. J. Clin. Nutr., 1999, 70(3), 412-9.
98. Steffen, L. M.; Jacobs, D. R., Jr.; Stevens, J.; Shahar, E.; Carithers, T.; Folsom, A. R. Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr., 2003, 78 (3), 383-90.
99. Jensen, M. K.; Koh-Banerjee, P.; Hu, F. B.; Franz, M.; Sampson, L.; Gronbaek, M.; Rimm, E. B. Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am. J. Clin. Nutr., 2004, 80(6), 1492-9.
100. Jacobs, D. R., Jr.; Meyer, H. E.; Solvoll, K. Reduced mortality among whole grain bread eaters in men and women in the Norwegian County Study. Eur. J. Clin. Nutr., 2001, 55(2), 137-43.
101. Mellen, P. B.; Walsh, T. F.; Herrington, D. M. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr. Metab. Cardiovasc. Dis., 2008, 18(4), 283-90.
102. Kelly, S. A.; Summerbell, C. D.; Brynes, A.; Whittaker, V.; Frost, G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst. Rev., 2007, (2), CD005051.
103. Andersson, A.; Tengblad, S.; Karlstrom, B.; Kamal-Eldin, A.; Landberg, R.; Basu, S.; Aman, P.; Vessby, B. Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J. Nutr., 2007, 137(6), 1401-7.
104. Brownlee, I. A.; Moore, C.; Chatfield, M.; Richardson, D. P.; Ashby, P.; Kuznesof, S. A.; Jebb, S. A.; Seal, C. J. Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br. J. Nutr., 2010, 104(1), 125-34.
105. Viuda-Martos, M.; López-Marcos, M. C.; Fernández-López, J.; Sendra, E.; López-Vargas, J. H.; Pérez-Álvarez, J. A., Role of Fiber in Cardiovascular Diseases: A Review. Compr. Rev. Food Sci. Food Saf., 2010, 9, 240-258.
106. de Koning, L.; Hu, F. B. Do the health benefits of dietary fiber extend beyond cardiovascular disease? Arch. Intern. Med., 2011, 171(12), 1069-70.
107. Salas-Salvado, J.; Bullo, M.; Perez-Heras, A.; Ros, E. Dietary fibre, nuts and cardiovascular diseases. Br. J. Nutr., 2006, 96(2), S46-51.
108. Liu, S.; Buring, J. E.; Sesso, H. D.; Rimm, E. B.; Willett, W. C.; Manson, J. E. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J. Am. Coll. Cardiol., 2002, 39(1), 49-56.
109. Mozaffarian, D.; Kumanyika, S. K.; Lemaitre, R. N.; Olson, J. L.; Burke, G. L.; Siscovick, D. S. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA, 2003, 289(13), 1659-66.
110. Pereira, M. A.; O'Reilly, E.; Augustsson, K.; Fraser, G. E.; Goldbourt, U.; Heitmann, B. L.; Hallmans, G.; Knekt, P.; Liu, S.; Pietinen, P.; Spiegelman, D.; Stevens, J.; Virtamo, J.; Willett, W. C.; Ascherio, A. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch. Intern. Med., 2004, 164, 370-6.
111. Streppel, M. T.; Ocke, M. C.; Boshuizen, H. C.; Kok, F. J.; Kromhout, D. Dietary fiber intake in relation to coronary heart disease and all-cause mortality over 40 y: the Zutphen Study. Am. J. Clin. Nutr., 2008, 88(4), 1119-25.
112. Eshak, E. S.; Iso, H.; Date, C.; Kikuchi, S.; Watanabe, Y.; Wada, Y.; Wakai, K.; Tamakoshi, A. Dietary fiber intake is associated with reduced risk of mortality from cardiovascular disease among Japanese men and women. J. Nutr., 2010, 140(8), 1445-53.
113. Kokubo, Y.; Iso, H.; Saito, I.; Yamagishi, K.; Ishihara, J.; Inoue, M.; Tsugane, S. Dietary fiber intake and risk of cardiovascular disease in the Japanese population: the Japan Public Health Centerbased study cohort. Eur. J. Clin. Nutr., 2011, 65(11), 1233-41.
114. Brown, L.; Rosner, B.; Willett, W. W.; Sacks, F. M. Cholesterollowering effects of dietary fiber: a meta-analysis. Am. J. Clin. Nutr., 1999, 69(1), 30-42.
115. Talati, R.; Baker, W. L.; Pabilonia, M. S.; White, C. M.; Coleman, C. I. The effects of barley-derived soluble fiber on serum lipids. Ann. Fam. Med., 2009, 7(2), 157-63.
116. Streppel, M. T.; Arends, L. R.; van 't Veer, P.; Grobbee, D. E.; Geleijnse, J. M. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch. Intern. Med., 2005, 165 (2), 150-6.
117. Whelton, P. K.; He, J.; Cutler, J. A.; Brancati, F. L.; Appel, L. J.; Follmann, D.; Klag, M. J. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA, 1997, 277(20), 1624-32.
118. Jee, S. H.; Miller, E. R., 3rd; Guallar, E.; Singh, V. K.; Appel, L. J.; Klag, M. J. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am. J. Hypertens, 2002, 15(8), 691-6.
119. Coudray, C.; Demigne, C.; Rayssiguier, Y. Effects of dietary fibers on magnesium absorption in animals and humans. J. Nutr., 2003, 133(1), 1-4.
120. King, D. E.; Egan, B. M.; Woolson, R. F.; Mainous, A. G.; 3rd; Al-Solaiman, Y.; Jesri, A. Effect of a high-fiber diet vs a fibersupplemented diet on C-reactive protein level. Arch. Intern. Med., 2007, 167(5), 502-6.
121. King, D. E.; Mainous, A. G., 3rd; Egan, B. M.; Woolson, R. F.; Geesey, M. E. Effect of psyllium fiber supplementation on Creactive protein: the trial to reduce inflammatory markers (TRIM). Ann. Fam. Med., 2008, 6(2), 100-6.
122. Ajani, U. A.; Ford, E. S.; Mokdad, A. H. Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J. Nutr., 2004, 134(5), 1181-5.
123. Ma, Y.; Griffith, J. A.; Chasan-Taber, L.; Olendzki, B. C.; Jackson, E.; Stanek, E. J., 3rd; Li, W.; Pagoto, S. L.; Hafner, A. R.; Ockene, I. S. Association between dietary fiber and serum C-reactive protein. Am. J. Clin. Nutr., 2006, 83(4), 760-6.
124. King, D. E.; Egan, B. M.; Geesey, M. E. Relation of dietary fat and fiber to elevation of C-reactive protein. Am. J. Cardiol., 2003, 92(11), 1335-9.
125. North, C. J.; Venter, C. S.; Jerling, J. C. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur. J. Clin. Nutr., 2009, 63(8), 921-33.
126. Brown, I. J.; Tzoulaki, I.; Candeias, V.; Elliott, P. Salt intakes around the world: implications for public health. Int. J. Epidemiol., 2009, 38(3), 791-813.
127. Wyness, L. A.; Butriss, J. L.; Stanner, S. A. Reducing the population's sodium intake: the UK Food Standards Agency's salt reduction programme. Public Health Nutr., 2012, 15(2), 254-61.
128. He, F. J.; MacGregor, G. A., Reducing population salt intake worldwide: from evidence to implementation. Prog. Cardiovasc. Dis. 2010, 52 (5), 363-82.
129. He, J.; Whelton, P. K., Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge. Int. J. Epidemiol., 2002, 31(2), 327-31.
130. Cook, N. R.; Cutler, J. A.; Obarzanek, E.; Buring, J. E.; Rexrode, K. M.; Kumanyika, S. K.; Appel, L. J.; Whelton, P. K. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ., 2007, 334 (7599), 885-8.
131. Stolarz-Skrzypek, K.; Kuznetsova, T.; Thijs, L.; Tikhonoff, V.; Seidlerova, J.; Richart, T.; Jin, Y.; Olszanecka, A.; Malyutina, S.; Casiglia, E.; Filipovsky, J.; Kawecka-Jaszcz, K.; Nikitin, Y.; Staessen, J. A., Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305 (17), 1777-85.
132. Bray, G. A.; Vollmer, W. M.; Sacks, F. M.; Obarzanek, E.; Svetkey, L. P.; Appel, L. J.; DASH Collaborative Research Group, A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASHSodium Trial. Am. J. Cardiol., 2004, 94, 222-7.
133. Sacks, F. M.; Svetkey, L. P.; Vollmer, W. M.; Appel, L. J.; Bray, G. A.; Harsha, D.; Obarzanek, E.; Conlin, P. R.; Miller, E. R., 3rd; Simons-Morton, D. G.; Karanja, N.; Lin, P. H. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med., 2001, 344(1), 3-10.
134. He, F.; MacGregor, G. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst. Rev., 2004, (1), CD004937.
135. Hooper, L.; Bartlett, C.; Davey Smith, G.; Ebrahim, S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst. Rev., 2004, (1), CD003656.
136. Taylor, R.; Ashton, K.; Moxham, T.; Hooper, L.; Ebrahim, S., Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst. Rev., 2011, (7), CD009217.
137. Grim, C. E.; Luft, F. C.; Miller, J. Z.; Meneely, G. R.; Battarbee, H. D.; Hames, C. G.; Dahl, L. K. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J. Chronic Dis., 1980, 33 (2), 87-94.
138. Lever, A. F.; Beretta-Piccoli, C.; Brown, J. J.; Davies, D. L.; Fraser, R.; Robertson, J. I. Sodium and potassium in essential hypertension. BMJ, 1981, 283(6289), 463-8.
139. Ophir, O.; Peer, G.; Gilad, J.; Blum, M.; Aviram, A. Low blood pressure in vegetarians: the possible role of potassium. Am. J. Clin. Nutr., 1983, 37(5), 755-62.
140. Ascherio, A.; Rimm, E. B.; Giovannucci, E. L.; Colditz, G. A.; Rosner, B.; Willett, W. C.; Sacks, F.; Stampfer, M. J. A prospective study of nutritional factors and hypertension among US men. Circulation, 1992, 86(5), 1475-84.
141. Ascherio, A.; Hennekens, C.; Willett, W. C.; Sacks, F.; Rosner, B.; Manson, J.; Witteman, J.; Stampfer, M. J. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension, 1996, 27(5), 1065-72.
142. Lai, S. H.; Tang, Y. C.; He, W. L.; Mo, P. S.; He, G. Q. Urinary electrolytes and blood pressure in three Yi farmer populations, China. Hypertension, 1989, 13(1), 22-30.
143. Dickinson, H.; Nicolson, D.; Campbell, F.; Beyer, F.; Mason, J., Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst. Rev., 2006, (3), CD004641.
144. Hamet, P. The evaluation of the scientific evidence for a relationship between calcium and hypertension. J. Nutr., 1995, 125 (2), 311S-400S.
145. Cutler, J. A.; Brittain, E. Calcium and blood pressure. An epidemiologic perspective. Am. J. Hypertens., 1990, 3(8 Pt 2), 137S-146S.
146. Burgess, E.; Lewanczuk, R.; Bolli, P.; Chockalingam, A.; Cutler, H.; Taylor, G.; Hamet, P. Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ, 1999, 160 (9), S35-45.
147. Cappuccio, F. P.; Elliott, P.; Allender, P. S.; Pryer, J.; Follman, D. A.; Cutler, J. A. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am. J. Epidemiol., 1995, 142(9), 935-45.
148. Dickinson, H.; Nicolson, D.; Cook, J.; Campbell, F.; Beyer, F.; Ford, G.; Mason, J. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst. Rev., 2006, (2), CD004639.
149. Beyer, F.; Dickinson, H.; Nicolson, D.; Ford, G.; Mason, J. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst. Rev., 2006, (3), CD004805.
150. Rimm, E. B.; Stampfer, M. J.; Ascherio, A.; Giovannucci, E.; Colditz, G. A.; Willett, W. C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med., 1993, 328(20), 1450-6.
151. Vivekananthan, D. P.; Penn, M. S.; Sapp, S. K.; Hsu, A.; Topol, E. J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet, 2003, 361 (9374), 2017-23.
152. Reaven, P. D.; Khouw, A.; Beltz, W. F.; Parthasarathy, S.; Witztum, J. L. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler. Thromb., 1993, 13(4), 590-600.
153. Redlich, C. A.; Chung, J. S.; Cullen, M. R.; Blaner, W. S.; Van Bennekum, A. M.; Berglund, L. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis, 1999, 145(2), 425-32.
154. Schurks, M.; Glynn, R. J.; Rist, P. M.; Tzourio, C.; Kurth, T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ, 2010, 341, c5702.
155. Guarnieri, S.; Riso, P.; Porrini, M. Orange juice vs vitamin C: effect on hydrogen peroxide-induced DNA damage in mononuclear blood cells. Br. J. Nutr., 2007, 97(4), 639-43.
156. Humphrey, L. L.; Fu, R.; Rogers, K.; Freeman, M.; Helfand, M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin. Proc., 2008, 83 (11), 1203-12.
157. Marti-Carvajal Arturo, J.; Sol, I.; Lathyris, D.; Salanti, G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst. Rev., 2009, (4), CD006612.
158. Galan, P.; Kesse-Guyot, E.; Czernichow, S.; Briancon, S.; Blacher, J.; Hercberg, S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ, 2010, 341, c6273.
159. Armitage, J. M.; Bowman, L.; Clarke, R. J.; Wallendszus, K.; Bulbulia, R.; Rahimi, K.; Haynes, R.; Parish, S.; Sleight, P.; Peto, R.; Collins, R. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA, 2010, 303(24), 2486-94.
160. Hankey GJ; Eikelboom JW; Baker RI; Gelavis A; Hickling SC; Jamrozik K; van Bockxmeer FM; Vasikaran S; Chen C; Eikelboom JW; KR, L. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol., 2010, 9(9), 855-65.
161. Zhou, Y. H.; Tang, J. Y.; Wu, M. J.; Lu, J.; Wei, X.; Qin, Y. Y.; Wang, C.; Xu, J. F.; He, J. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS ONE, 2011, 6(9), e25142.
162. Pilz, S.; Dobnig, H.; Nijpels, G.; Heine, R. J.; Stehouwer, C. D.; Snijder, M. B.; van Dam, R. M.; Dekker, J. M. Vitamin D and mortality in older men and women. Clin. Endocrinol. (Oxf.) 2009, 71(5), 666-72.
163. Kilkkinen, A.; Knekt, P.; Aro, A.; Rissanen, H.; Marniemi, J.; Heliovaara, M.; Impivaara, O.; Reunanen, A. Vitamin D status and the risk of cardiovascular disease death. Am. J. Epidemiol., 2009, 170 (8), 1032-9.
164. Pilz, S.; Dobnig, H.; Fischer, J. E.; Wellnitz, B.; Seelhorst, U.; Boehm, B. O.; Marz, W. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke, 2008, 39(9), 2611-3.
165. Kendrick, J.; Targher, G.; Smits, G.; Chonchol, M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis, 2009, 205(1), 255-60.
166. Mente, A.; de Koning, L.; Shannon, H. S.; Anand, S. S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med., 2009, 169(7), 659-69.
167. Bhupathiraju, S. N.; Tucker, K. L. Coronary heart disease prevention: nutrients, foods, and dietary patterns. Clin. Chim. Acta, 2011, 412(17-18), 1493-514.